Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
15.51
-2.19 (-12.37%)
May 13, 2025, 4:00 PM - Market closed
Neurogene Revenue
Neurogene had revenue of $925.00K in the twelve months ending March 31, 2025. In the year 2024, Neurogene had annual revenue of $925.00K.
Revenue (ttm)
$925.00K
Revenue Growth
n/a
P/S Ratio
239.14
Revenue / Employee
$8,645
Employees
107
Market Cap
221.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 925.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNGNE News
- 5 days ago - Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Business Wire
- 5 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting - Business Wire
- 5 weeks ago - Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome - Business Wire
- 7 weeks ago - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates - Business Wire
- 2 months ago - Neurogene to Participate in Upcoming Conferences - Business Wire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Shareholders to Learn More About the Investigation - Accesswire